- Published on
Toxicology – Alpha-Blocker Toxicity
Source
Alpha-adrenergic blockers include medications such as prazosin, terazosin, doxazosin, and tamsulosin. These drugs are used in the management of hypertension, benign prostatic hyperplasia (BPH), post-traumatic stress disorder (PTSD), and certain anxiety conditions.
Typical Presentation
Toxicity often presents with episodes of dizziness or fainting, especially after standing. Patients may report weakness and lightheadedness following overdose or excessive dosing.
Clinical Features
Common symptoms include orthostatic (postural) hypotension, dizziness, syncope, headache, nausea, generalized weakness, palpitations, and reflex tachycardia. These effects are primarily due to vasodilation and reduced vascular tone.
Mechanism of Action
Alpha-blockers inhibit alpha-adrenergic receptors. Blockade of α1 receptors leads to relaxation of vascular smooth muscle, resulting in decreased peripheral resistance and blood pressure. This vasodilation causes venous pooling, particularly when standing, leading to orthostatic hypotension. Because there is no direct suppression of cardiac function, the body compensates with reflex tachycardia.
Management
Treatment is supportive. Intravenous fluids are used to restore circulating volume. Positioning the patient supine or in the Trendelenburg position can help improve blood pressure. Activated charcoal may be considered in early presentations.
Key Points
Source
Alpha-adrenergic blockers include medications such as prazosin, terazosin, doxazosin, and tamsulosin. These drugs are used in the management of hypertension, benign prostatic hyperplasia (BPH), post-traumatic stress disorder (PTSD), and certain anxiety conditions.
Typical Presentation
Toxicity often presents with episodes of dizziness or fainting, especially after standing. Patients may report weakness and lightheadedness following overdose or excessive dosing.
Clinical Features
Common symptoms include orthostatic (postural) hypotension, dizziness, syncope, headache, nausea, generalized weakness, palpitations, and reflex tachycardia. These effects are primarily due to vasodilation and reduced vascular tone.
Mechanism of Action
Alpha-blockers inhibit alpha-adrenergic receptors. Blockade of α1 receptors leads to relaxation of vascular smooth muscle, resulting in decreased peripheral resistance and blood pressure. This vasodilation causes venous pooling, particularly when standing, leading to orthostatic hypotension. Because there is no direct suppression of cardiac function, the body compensates with reflex tachycardia.
Management
Treatment is supportive. Intravenous fluids are used to restore circulating volume. Positioning the patient supine or in the Trendelenburg position can help improve blood pressure. Activated charcoal may be considered in early presentations.
Key Points
- Orthostatic hypotension is a hallmark feature of toxicity.
- Reflex tachycardia occurs due to compensatory mechanisms.
- Tamsulosin is more selective for α1 receptors in the urinary tract and typically has less effect on systemic blood pressure at therapeutic doses.
- Published on
Toxicology – Salicylate Toxicity
Source
Salicylates are present in many over-the-counter and prescription medications used for pain, fever, and inflammation. Common sources include aspirin, methyl salicylate (oil of wintergreen), combination cold remedies, topical analgesics, bismuth subsalicylate (e.g., Pepto-Bismol), and effervescent formulations like Alka-Seltzer.
Typical Presentation
Toxicity may occur acutely after a large ingestion or chronically from repeated high dosing, especially in elderly patients. Acute cases often present with gastrointestinal and auditory symptoms, whereas chronic toxicity may present more subtly.
Clinical Features
Acute Toxicity
Patients commonly develop nausea, vomiting, abdominal pain, rapid breathing (tachypnea), ringing in the ears (tinnitus), and confusion. Severe cases may progress to hypoglycemia, seizures, pulmonary edema, and coma. A classic finding is a mixed acid–base disorder: respiratory alkalosis combined with metabolic acidosis.
Chronic Toxicity
Typically seen in older individuals, presenting with confusion, dehydration, and metabolic acidosis. Symptoms are often nonspecific and can mimic other illnesses, making diagnosis more challenging.
Mechanism of Action
Salicylates stimulate the respiratory center in the brain, causing hyperventilation and respiratory alkalosis. They also uncouple oxidative phosphorylation, leading to increased acid production and metabolic acidosis. Additionally, they irreversibly inhibit cyclooxygenase (COX) enzymes.
Management
Treatment is supportive and includes careful monitoring. If intubation is required, maintaining adequate hyperventilation is critical to prevent worsening acidosis. Sodium bicarbonate is administered to alkalinize the blood (target pH ≥7.4) and urine (target pH 7.5–8.5), which enhances salicylate elimination.
Gastrointestinal decontamination with multiple-dose activated charcoal or whole bowel irrigation may be considered. Hemodialysis is indicated in severe toxicity, particularly with high salicylate levels or significant clinical deterioration. Patients should also be monitored for complications such as pulmonary edema.
Key Points
Source
Salicylates are present in many over-the-counter and prescription medications used for pain, fever, and inflammation. Common sources include aspirin, methyl salicylate (oil of wintergreen), combination cold remedies, topical analgesics, bismuth subsalicylate (e.g., Pepto-Bismol), and effervescent formulations like Alka-Seltzer.
Typical Presentation
Toxicity may occur acutely after a large ingestion or chronically from repeated high dosing, especially in elderly patients. Acute cases often present with gastrointestinal and auditory symptoms, whereas chronic toxicity may present more subtly.
Clinical Features
Acute Toxicity
Patients commonly develop nausea, vomiting, abdominal pain, rapid breathing (tachypnea), ringing in the ears (tinnitus), and confusion. Severe cases may progress to hypoglycemia, seizures, pulmonary edema, and coma. A classic finding is a mixed acid–base disorder: respiratory alkalosis combined with metabolic acidosis.
Chronic Toxicity
Typically seen in older individuals, presenting with confusion, dehydration, and metabolic acidosis. Symptoms are often nonspecific and can mimic other illnesses, making diagnosis more challenging.
Mechanism of Action
Salicylates stimulate the respiratory center in the brain, causing hyperventilation and respiratory alkalosis. They also uncouple oxidative phosphorylation, leading to increased acid production and metabolic acidosis. Additionally, they irreversibly inhibit cyclooxygenase (COX) enzymes.
Management
Treatment is supportive and includes careful monitoring. If intubation is required, maintaining adequate hyperventilation is critical to prevent worsening acidosis. Sodium bicarbonate is administered to alkalinize the blood (target pH ≥7.4) and urine (target pH 7.5–8.5), which enhances salicylate elimination.
Gastrointestinal decontamination with multiple-dose activated charcoal or whole bowel irrigation may be considered. Hemodialysis is indicated in severe toxicity, particularly with high salicylate levels or significant clinical deterioration. Patients should also be monitored for complications such as pulmonary edema.
Key Points
- Chronic toxicity is often missed due to nonspecific symptoms.
- Mixed respiratory alkalosis and metabolic acidosis is a hallmark finding.
- Oil of wintergreen is highly concentrated and potentially lethal, especially in children.
- Chronic toxicity generally carries a worse prognosis than acute overdose.
- Adequate ventilation must be maintained in intubated patients.
- Published on
Toxicology – Isopropyl Alcohol (Isopropanol) Toxicity
Source
Isopropyl alcohol is commonly found in products such as rubbing alcohol, disinfectants, cleaning solutions, deicers, solvents, and certain fuel additives.
Typical Presentation
Patients often present with signs of significant intoxication, sometimes mistaken for ethanol ingestion. A distinguishing clue may be a fruity or acetone-like odor on the breath.
Clinical Features
This produces a hypnosedative toxidrome, often more intense than ethanol. Symptoms include slurred speech, impaired coordination, unsteady gait, nystagmus, confusion, and disinhibition. Severe cases may progress to hypotension, hypothermia, coma, and respiratory arrest.
Gastrointestinal irritation is prominent, with abdominal pain and possible hemorrhagic gastritis or esophagitis. Laboratory findings may show:
Mechanism of Action
Isopropanol acts as a central nervous system depressant via GABA receptor activity. It is metabolized by alcohol dehydrogenase into acetone, which is less toxic and responsible for the characteristic fruity odor.
Management
Treatment is primarily supportive:
Hemodialysis may be considered in severe cases, particularly when there is persistent coma or refractory hypotension. Unlike other toxic alcohols, antidotes such as fomepizole are not used because the metabolite (acetone) is not highly toxic.
Key Points
Source
Isopropyl alcohol is commonly found in products such as rubbing alcohol, disinfectants, cleaning solutions, deicers, solvents, and certain fuel additives.
Typical Presentation
Patients often present with signs of significant intoxication, sometimes mistaken for ethanol ingestion. A distinguishing clue may be a fruity or acetone-like odor on the breath.
Clinical Features
This produces a hypnosedative toxidrome, often more intense than ethanol. Symptoms include slurred speech, impaired coordination, unsteady gait, nystagmus, confusion, and disinhibition. Severe cases may progress to hypotension, hypothermia, coma, and respiratory arrest.
Gastrointestinal irritation is prominent, with abdominal pain and possible hemorrhagic gastritis or esophagitis. Laboratory findings may show:
- Increased osmolal gap
- Presence of ketones (without significant acidosis)
- Nongap metabolic acidosis
- Falsely elevated creatinine
Mechanism of Action
Isopropanol acts as a central nervous system depressant via GABA receptor activity. It is metabolized by alcohol dehydrogenase into acetone, which is less toxic and responsible for the characteristic fruity odor.
Management
Treatment is primarily supportive:
- Airway protection and monitoring
- Intravenous fluids for hypotension
- Vasopressors if needed
Hemodialysis may be considered in severe cases, particularly when there is persistent coma or refractory hypotension. Unlike other toxic alcohols, antidotes such as fomepizole are not used because the metabolite (acetone) is not highly toxic.
Key Points
- More potent intoxicant than ethanol.
- Causes ketosis without significant anion gap acidosis.
- Fruity breath odor is due to acetone formation.
- Management is usually supportive, with dialysis reserved for severe toxicity.
- Published on
Toxicology – Levamisole Toxicity (Cocaine Adulterant)
Source
Levamisole is a medication originally used as an antiparasitic agent in veterinary medicine. It is now commonly encountered as an adulterant mixed with cocaine to enhance its appearance and perceived potency.
Typical Presentation
Patients are often individuals with a history of cocaine use who present with unexplained infections or unusual skin findings. Symptoms may develop after repeated exposure.
Clinical Features
A hallmark feature is vasculitis, appearing as purplish skin lesions, often involving the ears, face, and lower limbs. Patients may also experience fever and chills.
Laboratory findings frequently reveal severe neutropenia or agranulocytosis, increasing the risk of serious infections. In some cases, neurological complications such as leukoencephalopathy have been reported.
Mechanism of Action
Levamisole acts as an immunomodulatory agent. In humans, it can suppress bone marrow function in a dose-dependent manner, leading to dangerously low white blood cell counts. Its continued presence in illicit drugs contributes to repeated toxic exposure.
Management
Treatment primarily involves stopping exposure to the contaminated substance and providing supportive care. Management of infections and monitoring of blood counts are essential.
Key Points
Source
Levamisole is a medication originally used as an antiparasitic agent in veterinary medicine. It is now commonly encountered as an adulterant mixed with cocaine to enhance its appearance and perceived potency.
Typical Presentation
Patients are often individuals with a history of cocaine use who present with unexplained infections or unusual skin findings. Symptoms may develop after repeated exposure.
Clinical Features
A hallmark feature is vasculitis, appearing as purplish skin lesions, often involving the ears, face, and lower limbs. Patients may also experience fever and chills.
Laboratory findings frequently reveal severe neutropenia or agranulocytosis, increasing the risk of serious infections. In some cases, neurological complications such as leukoencephalopathy have been reported.
Mechanism of Action
Levamisole acts as an immunomodulatory agent. In humans, it can suppress bone marrow function in a dose-dependent manner, leading to dangerously low white blood cell counts. Its continued presence in illicit drugs contributes to repeated toxic exposure.
Management
Treatment primarily involves stopping exposure to the contaminated substance and providing supportive care. Management of infections and monitoring of blood counts are essential.
Key Points
- Strongly associated with cocaine use due to drug adulteration.
- Causes characteristic purplish skin lesions (vasculitis).
- Can lead to severe immune suppression (agranulocytosis).
- Risk of infection is high due to low white blood cell counts.
- May cause adverse reactions when combined with alcohol.
- Published on
Toxicology – Ethylene Glycol (Antifreeze Poisoning)
Source
Ethylene glycol is commonly found in antifreeze and hydraulic brake fluids. Its sweet taste increases the risk of accidental ingestion, especially in children and animals.
Typical Presentation
Patients often present hours after ingestion with progressive symptoms that evolve in stages, beginning with neurological and gastrointestinal complaints and later affecting the heart, lungs, and kidneys.
Clinical Features
Ethylene glycol toxicity typically progresses through three stages:
Ethylene glycol itself is not highly toxic, but it is metabolized into harmful compounds such as glycolic acid and oxalic acid. Glycolic acid causes severe metabolic acidosis and cellular damage, while oxalic acid binds calcium to form crystals that deposit in the kidneys, leading to renal failure.
Management
Treatment focuses on preventing toxic metabolite formation and enhancing elimination:
Source
Ethylene glycol is commonly found in antifreeze and hydraulic brake fluids. Its sweet taste increases the risk of accidental ingestion, especially in children and animals.
Typical Presentation
Patients often present hours after ingestion with progressive symptoms that evolve in stages, beginning with neurological and gastrointestinal complaints and later affecting the heart, lungs, and kidneys.
Clinical Features
Ethylene glycol toxicity typically progresses through three stages:
- Stage I (30 min–12 hrs): Early symptoms resemble alcohol intoxication, including confusion, dizziness, slurred speech, nausea, vomiting, and abdominal pain.
- Stage II (12–36 hrs): Cardiopulmonary effects develop, including rapid heart rate, elevated blood pressure, rapid breathing, and severe metabolic acidosis. Low calcium levels may cause muscle spasms, tetany, and decreased reflexes. Serious complications include brain swelling, lung injury, and cardiovascular collapse.
- Stage III (24–72 hrs): Kidney injury becomes prominent, with decreased urine output, blood or protein in urine, electrolyte disturbances, and possible kidney failure.
Ethylene glycol itself is not highly toxic, but it is metabolized into harmful compounds such as glycolic acid and oxalic acid. Glycolic acid causes severe metabolic acidosis and cellular damage, while oxalic acid binds calcium to form crystals that deposit in the kidneys, leading to renal failure.
Management
Treatment focuses on preventing toxic metabolite formation and enhancing elimination:
- Fomepizole is the preferred antidote; it blocks alcohol dehydrogenase.
- Ethanol may be used if fomepizole is unavailable.
- Hemodialysis is indicated in severe cases to remove toxins and correct acidosis.
- Thiamine and pyridoxine help shift metabolism toward less harmful pathways.
- Sweet taste increases risk of accidental ingestion.
- Severe metabolic acidosis is a hallmark finding.
- Calcium oxalate crystals may be seen in urine.
- Kidney failure is a major late complication.
- Early treatment is critical to prevent irreversible damage.
- Published on
Toxicology – Strychnine Poisoning
Source
Strychnine is a naturally occurring toxin derived from the seeds of the Strychnos nux-vomica tree. It is commonly used in rodenticides and pest control products and may also be found as an adulterant in illicit drugs.
Typical Presentation
Exposure typically follows ingestion or inhalation. Patients often present with sudden onset of severe muscle spasms and convulsions, sometimes after accidental or intentional ingestion of poison products.
Clinical Features
Early signs include anxiety, increased salivation, and dilated pupils. Rapidly, painful muscle spasms begin in the face and neck—manifesting as grimacing (risus sardonicus) and jaw stiffness (trismus)—then spread to the entire body.
Patients develop intense, prolonged muscle contractions (tetany), often with a characteristic arching posture (opisthotonus). Unlike typical seizures, patients may remain conscious and aware during these episodes. Severe complications include:
Strychnine blocks the inhibitory neurotransmitter glycine in the central nervous system, particularly at the spinal cord level. Without glycine’s inhibitory effect, motor neurons become overactive, leading to uncontrolled muscle contractions and spasms.
Management
Treatment is supportive and focused on controlling muscle activity and protecting the airway:
Source
Strychnine is a naturally occurring toxin derived from the seeds of the Strychnos nux-vomica tree. It is commonly used in rodenticides and pest control products and may also be found as an adulterant in illicit drugs.
Typical Presentation
Exposure typically follows ingestion or inhalation. Patients often present with sudden onset of severe muscle spasms and convulsions, sometimes after accidental or intentional ingestion of poison products.
Clinical Features
Early signs include anxiety, increased salivation, and dilated pupils. Rapidly, painful muscle spasms begin in the face and neck—manifesting as grimacing (risus sardonicus) and jaw stiffness (trismus)—then spread to the entire body.
Patients develop intense, prolonged muscle contractions (tetany), often with a characteristic arching posture (opisthotonus). Unlike typical seizures, patients may remain conscious and aware during these episodes. Severe complications include:
- Rhabdomyolysis
- Hyperthermia
- Metabolic (lactic) acidosis
- Respiratory failure due to sustained muscle contraction
Strychnine blocks the inhibitory neurotransmitter glycine in the central nervous system, particularly at the spinal cord level. Without glycine’s inhibitory effect, motor neurons become overactive, leading to uncontrolled muscle contractions and spasms.
Management
Treatment is supportive and focused on controlling muscle activity and protecting the airway:
- Benzodiazepines and barbiturates for seizure and spasm control
- Early intubation with sedation and use of nondepolarizing paralytics (e.g., rocuronium, vecuronium)
- IV fluids for rhabdomyolysis
- Active cooling for hyperthermia
- Patients may remain conscious during severe spasms (“conscious seizures”).
- Avoid succinylcholine, as it can worsen muscle contractions.
- Respiratory failure is a major cause of death.
- Rapid, aggressive supportive care is critical.
- Published on
Toxicology – Lithium Toxicity
Source
Lithium carbonate is commonly prescribed for bipolar disorder. It is also used in industrial settings, including fireworks production.
Typical Presentation
Toxicity may occur from acute overdose, chronic accumulation, or a combination of both. Patients on long-term therapy are especially at risk if kidney function declines or if interacting medications are introduced.
Clinical Features
Lithium toxicity presents in three main patterns:
Lithium affects multiple intracellular pathways, including inhibition of signaling systems and neurotransmitter modulation. It is eliminated almost entirely by the kidneys, making renal function a key factor in toxicity.
Management
Treatment is supportive and focuses on enhancing elimination:
Source
Lithium carbonate is commonly prescribed for bipolar disorder. It is also used in industrial settings, including fireworks production.
Typical Presentation
Toxicity may occur from acute overdose, chronic accumulation, or a combination of both. Patients on long-term therapy are especially at risk if kidney function declines or if interacting medications are introduced.
Clinical Features
Lithium toxicity presents in three main patterns:
- Acute toxicity: Predominantly gastrointestinal symptoms such as nausea, vomiting, diarrhea, and dizziness. Kidney injury and mild cardiac changes (e.g., QT prolongation) may occur.
- Chronic toxicity: Mainly neurological symptoms including tremor, weakness, hyperreflexia, involuntary movements, poor coordination, confusion, and altered consciousness, which can progress to coma.
- Acute-on-chronic toxicity: A combination of both GI and neurological symptoms, often more severe.
Lithium affects multiple intracellular pathways, including inhibition of signaling systems and neurotransmitter modulation. It is eliminated almost entirely by the kidneys, making renal function a key factor in toxicity.
Management
Treatment is supportive and focuses on enhancing elimination:
- IV fluids to improve kidney perfusion and promote excretion
- Whole bowel irrigation for sustained-release ingestion
- Hemodialysis for severe cases (e.g., high lithium levels, neurological symptoms, or kidney impairment)
-
- Toxicity risk increases with dehydration, kidney dysfunction, and certain medications (e.g., NSAIDs, ACE inhibitors).
- Neurological symptoms are more prominent in chronic toxicity.
- Lithium levels may rise again after dialysis, requiring repeated treatments.
- Activated charcoal is not effective for lithium overdose.
- Therapeutic levels are typically 0.6–1.2 mEq/L.
- Published on
Toxicology – Hyperkalemia (Elevated Potassium Levels)
Source
Elevated potassium levels can result from potassium supplements, kidney failure (especially in dialysis patients), and certain medications such as ACE inhibitors, NSAIDs, and potassium-sparing diuretics. It may also occur due to cellular breakdown in conditions like rhabdomyolysis, hemolysis, or tumor lysis syndrome.
Typical Presentation
Patients may present with vague symptoms such as weakness or fatigue, but serious cases often involve cardiac abnormalities detected on ECG, especially in those with impaired kidney function.
Clinical Features
Symptoms are often nonspecific and may include:
High extracellular potassium alters the electrical gradient across cardiac cells, making them more excitable and prone to dangerous arrhythmias.
Management
Treatment is urgent and involves three main strategies:
Source
Elevated potassium levels can result from potassium supplements, kidney failure (especially in dialysis patients), and certain medications such as ACE inhibitors, NSAIDs, and potassium-sparing diuretics. It may also occur due to cellular breakdown in conditions like rhabdomyolysis, hemolysis, or tumor lysis syndrome.
Typical Presentation
Patients may present with vague symptoms such as weakness or fatigue, but serious cases often involve cardiac abnormalities detected on ECG, especially in those with impaired kidney function.
Clinical Features
Symptoms are often nonspecific and may include:
- Generalized weakness and malaise
- Slow heart rate (bradycardia)
- Cardiac arrhythmias
- Peaked T waves
- Prolonged PR interval
- Flattened or absent P waves
- Widened QRS complex
- “Sine wave” pattern leading to cardiac arrest
High extracellular potassium alters the electrical gradient across cardiac cells, making them more excitable and prone to dangerous arrhythmias.
Management
Treatment is urgent and involves three main strategies:
- Stabilize the heart
- IV calcium (calcium gluconate or calcium chloride) to protect cardiac membranes
- Shift potassium into cells
- Insulin with glucose
- β-agonists (e.g., high-dose nebulized albuterol)
- Sodium bicarbonate (in cases of acidosis)
- Remove potassium from the body
- Dialysis (most effective in severe cases)
- Potassium-binding resins (e.g., sodium polystyrene sulfonate)
- ECG monitoring is essential in suspected hyperkalemia.
- Calcium does not lower potassium—it stabilizes the heart.
- Severe hyperkalemia is a medical emergency due to risk of fatal arrhythmias.
- Kidney function plays a major role in potassium regulation.
- Published on
Toxicology – Digitalis (Digoxin) Toxicity
Source
Digoxin is a cardiac medication used to manage conditions like atrial fibrillation and heart failure. Similar cardiac glycosides are naturally found in plants such as foxglove, oleander, and milkweed, as well as in certain toads (e.g., Bufo species).
Typical Presentation
Patients—often elderly with underlying heart disease—may present with gastrointestinal complaints, abnormal heart rhythms, and visual disturbances. Toxicity can occur from acute overdose or chronic accumulation.
Clinical Features
Mechanism of Action
Digoxin works by inhibiting the sodium–potassium ATPase pump, which increases intracellular calcium and enhances cardiac contractility. It also increases vagal tone, slowing conduction through the heart. However, these same effects predispose to abnormal heart rhythms in overdose.
Management
Treatment focuses on stabilizing the patient and addressing arrhythmias:
Key Points
Source
Digoxin is a cardiac medication used to manage conditions like atrial fibrillation and heart failure. Similar cardiac glycosides are naturally found in plants such as foxglove, oleander, and milkweed, as well as in certain toads (e.g., Bufo species).
Typical Presentation
Patients—often elderly with underlying heart disease—may present with gastrointestinal complaints, abnormal heart rhythms, and visual disturbances. Toxicity can occur from acute overdose or chronic accumulation.
Clinical Features
- Acute toxicity: Symptoms usually appear several hours after ingestion and include nausea, vomiting, elevated potassium levels, and dangerous cardiac arrhythmias.
- Chronic toxicity: More subtle and varied, including fatigue, confusion, weakness, gastrointestinal upset, and visual changes (e.g., blurred vision, yellow-tinted vision or “xanthopsia”).
Mechanism of Action
Digoxin works by inhibiting the sodium–potassium ATPase pump, which increases intracellular calcium and enhances cardiac contractility. It also increases vagal tone, slowing conduction through the heart. However, these same effects predispose to abnormal heart rhythms in overdose.
Management
Treatment focuses on stabilizing the patient and addressing arrhythmias:
- Supportive care with cardiac monitoring
- Atropine for symptomatic bradycardia
- Correction of electrolyte imbalances (especially potassium and magnesium)
- Activated charcoal if ingestion is recent
- Digoxin-specific antibody fragments (Digoxin immune Fab) for severe toxicity (e.g., life-threatening arrhythmias, high potassium, or hemodynamic instability)
Key Points
- Toxicity can be acute or chronic, with different clinical patterns.
- Visual disturbances are a classic clue.
- Hyperkalemia in acute toxicity is a poor prognostic sign.
- Digoxin levels should be interpreted carefully, especially early after ingestion.
- Antibody therapy is the definitive treatment in severe cases.
- Published on
Toxicology – Methylxanthine Toxicity (Caffeine, Theophylline, Theobromine)
Source
Methylxanthines include compounds such as caffeine, theophylline (used in respiratory diseases), and theobromine (found in chocolate). These substances are present in beverages, medications, and certain foods.
Typical Presentation
Toxicity often results from overdose—intentional or accidental—and can present with both gastrointestinal and cardiovascular symptoms. Severe cases may rapidly progress to life-threatening complications.
Clinical Features
Early symptoms commonly include headache, nausea, vomiting (often persistent), abdominal discomfort, and diarrhea. As toxicity worsens, patients may develop:
Mechanism of Action
Methylxanthines exert multiple effects:
Management
Treatment is primarily supportive and may include:
Key Points
Source
Methylxanthines include compounds such as caffeine, theophylline (used in respiratory diseases), and theobromine (found in chocolate). These substances are present in beverages, medications, and certain foods.
Typical Presentation
Toxicity often results from overdose—intentional or accidental—and can present with both gastrointestinal and cardiovascular symptoms. Severe cases may rapidly progress to life-threatening complications.
Clinical Features
Early symptoms commonly include headache, nausea, vomiting (often persistent), abdominal discomfort, and diarrhea. As toxicity worsens, patients may develop:
- Rapid heart rate and breathing
- Low blood pressure with wide pulse pressure
- Tremors, agitation, and restlessness
- Seizures, including status epilepticus
- Cardiac arrhythmias (ranging from sinus tachycardia to ventricular fibrillation)
Mechanism of Action
Methylxanthines exert multiple effects:
- Block adenosine receptors (removing inhibitory CNS effects)
- Stimulate β-adrenergic activity, increasing heart rate and blood pressure
- Inhibit phosphodiesterase, leading to increased cAMP and intracellular calcium
Management
Treatment is primarily supportive and may include:
- IV fluids and vasopressors (e.g., norepinephrine or phenylephrine) for hypotension
- Benzodiazepines for seizures
- Management of arrhythmias (often with calcium channel blockers)
- Activated charcoal to reduce absorption
- Whole bowel irrigation for sustained-release ingestions
Key Points
- Severe toxicity can cause persistent vomiting, seizures, and dangerous arrhythmias.
- Theobromine is especially toxic to animals (e.g., dogs, rabbits).
- Dialysis is considered in life-threatening cases.
- Multidose activated charcoal may enhance elimination.
